<code id='25888C905A'></code><style id='25888C905A'></style>
    • <acronym id='25888C905A'></acronym>
      <center id='25888C905A'><center id='25888C905A'><tfoot id='25888C905A'></tfoot></center><abbr id='25888C905A'><dir id='25888C905A'><tfoot id='25888C905A'></tfoot><noframes id='25888C905A'>

    • <optgroup id='25888C905A'><strike id='25888C905A'><sup id='25888C905A'></sup></strike><code id='25888C905A'></code></optgroup>
        1. <b id='25888C905A'><label id='25888C905A'><select id='25888C905A'><dt id='25888C905A'><span id='25888C905A'></span></dt></select></label></b><u id='25888C905A'></u>
          <i id='25888C905A'><strike id='25888C905A'><tt id='25888C905A'><pre id='25888C905A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:hotspot    Page View:6534
          Katie Palmer, STAT (left) moderating the Doctor vs. ChatGPT session during the 2023 STAT Summit. STAT

          Generative AI tools are already helping doctors transcribe visits and summarize patient records. The technology behind ChatGPT, trained on vast amounts of data from the internet, made headlines when it correctly answered more than 80% of board exam questions. In July, a team at Beth Israel saw promising results when using GPT-4 during a diagnosis workshop for medical residents.

          But the tool is by no means ready for primetime. When given questions about real-life medical scenarios by Stanford researchers, GPT frequently disagreed with humans or offered irrelevant information. The AI models are prone to “hallucinating,” or making things up because they sound right — a tendency that could cause immeasurable harm if let loose on patients. AI leaders and policymakers alike have called for more regulations.

          advertisement

          STAT decided to put ChatGPT to the test at its annual summit on Wednesday, pitting the tool against Ann Woolley, infectious disease specialist at Brigham and Women’s Hospital. Marc Succi, the associate innovation chair at Mass General Brigham, gave two patient scenarios to the tool while Woolley explained her own diagnoses.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          FDA poised to publish guidelines for clinical trial diversity
          FDA poised to publish guidelines for clinical trial diversity

          AdobeTheFoodandDrugAdministrationispoisedtotelldrugandmedicaldevicemakershowtobetterincludepeopleofc

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Making the case for fair compensation in clinical trials

          AdobeI’vebeenonthreesidesofthehealthcareequation:I’vebeatenstage4colorectalcancer,I’mthemotherofason